XOMAP Q1 2025 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$16M+967.9% YoY

Gross Profit

$15M91.9% margin

Operating Income

$6M37.3% margin

Net Income

$2M14.9% margin

EPS (Diluted)

$0.06

QoQ Revenue Growth

+82.6%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$2M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$213M

Total Liabilities

$128M

Stockholders' Equity

$85M

Cash & Equivalents

$90M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$1M	+967.9%
Gross Profit	$15M	$1M	+882.5%
Operating Income	$6M	-$7M	+184.7%
Net Income	$2M	-$9M	+127.5%